ABSTRACT
Background: COVID-19 made it necessary to establish telemedicine as a first default for reviews in a previously telemedicine-naive clinic. Objectives: To establish and assess telemedicine in the first 6 months of COVID-19 pandemic. Methods: Utilising a multidisciplinary team (MDT) approach, we established a ‘Covid Pack’ of medical equipment (sent to each patient) and a suitable video conference platform to replicate the in-person clinic format. The virtual clinic was then rolled out (94 patients reviewed in the first 6 months). A retrospective chart review comparing patients’ clinical metrics pre- and post-rollout was then conducted. Usability and Acceptance were also measured with patients (p) and staff (s) via a number of standardised surveys: System Usability Scale (SUS), TeleHealth Usability Questionnaire (TUQ), IT Familiarity, and our own quality-survey. Results: The Covid Pack permits adequate spirometric assessment of patients (mean bias −2.5%). Preliminary data collected from 52 patients and 11 staff members show an overall positive response to our remoteclinics. The SUS received a median score of 90 (p) and 87.5 (s) out of 100. The TUQ received a total score of 6.52 (p) and 6.1 (s) out of 7, with ease of Use and Learnability as the highest-rated category in the TUQ (median 7, range 3.6–7) and Reliability as the lowest-rated category (median 5.33, range 2–7). The IT Familiarity questionnaire received an average median score of 1 (very familiar) from both groups. Qualitative data collected via a custom survey show that while patients and staff are positive to the convenience of the remote clinic, the facility for an in-person. face-to-face review remains important, as does good WiFi connection. Conclusion: Initial 6-month data are positive for the remote clinic as a first default during the pandemic. Preliminary data shows a positive trend for the usability and acceptance by all stakeholders, but it is not a replacement for physical clinics.
ABSTRACT
COVID-19 healthcare workers (HCWs) require frequent handwashing and use of personal protective equipment (PPE) to prevent infection. However, evidence is emerging that these practices are causing adverse effects on their skin integrity. A single-centre, cross-sectional study of HCWs from an Irish hospital was undertaken to evaluate the degree of COVID-19-related irritant contact dermatitis (ICD) between April and May 2020. Of 270 participants surveyed, 223 (82.6%) reported symptoms of ICD. The hands were the most commonly affected site (76.47%) and the most frequently reported symptom was dry skin (75.37%). Nearly all (268; 99.26%) HCWs had increased hand-washing frequency, but 122 (45.35%) did not use emollients. In the ICD group, 24.7% cited a history of dermatitis compared with 4.3% of unaffected staff (P < 0.001). The ICD group recorded PPE usage for an average of 3.15 h compared with the non-ICD group at 1.97 h (P = 0.21). Promoting awareness of COVID-19-related ICD is vital to highlight prevention and treatment for frontline staff.